Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 5Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 2Neoplasm Metastasis 2Triple Negative Breast Neoplasms 1Trigger Finger Disorder 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mesothelioma 1Median Neuropathy 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia 1Head and Neck Neoplasms 1Ganglion Cysts 1Emergence Delirium 1Delirium 1De Quervain Disease 1Carcinoma 1Burkitt Lymphoma 1Agnosia 1

Interventions

acetaminophen, aspirin, caffeine drug combination 1Tapentadol 1Surveys and Questionnaires 1Oxycodone 1Ketorolac 1Ketamine 1Fentanyl 1Dosage Forms 1Bupivacaine 1Analgesics 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Agnosia × Acetaminophen × Clear all
NCT05597878 2026-06-01

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Terminated
58 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡